Chiovato L, Vitti P, Bendinelli G, Santini F, Fiore E, Tonacchera M, Mammoli C, Capaccioli A, Venturi S, Pretell E
Istituto di Endocrinologia Università di Pisa, Italy.
J Clin Endocrinol Metab. 1995 May;80(5):1509-14. doi: 10.1210/jcem.80.5.7744994.
A role of thyroid autoimmunity in the pathogenesis of myxedematous endemic cretinism was suggested by reports indicating the presence of thyroid growth-blocking antibodies in the sera of these patients. To check this hypothesis, we searched for TSH receptor antibodies with thyroid growth-blocking or adenylate cyclase (AC)-inhibiting (TSH-blocking) activity in immunoglobulin G (IgG) from 18 euthyroid and 21 hypothyroid endemic cretins living in Italy and Peru. Among hypothyroid cretins, 12 had no palpable goiter. Stages I-III goiters were present in 12 of 18 euthyroid cretins. Controls included 25 euthyroid nongoitrous subjects living in the same endemic regions as cretins, and 10 normal subjects from an iodine-sufficient area. IgG from 4 selected patients with autoimmune atrophic thyroiditis and from 2 neonates with sporadic transient congenital hypothyroidism due to maternal TSH-blocking antibodies were included in the study. The blocking effect of the IgG was assessed in FRTL-5 cells by measuring TSH-stimulated [3H]thymidine incorporation, DNA accumulation, and AC activation. A radioreceptor assay was used to detect TSH-binding inhibiting antibodies (TBIAb). No IgG from hypothyroid endemic cretins without goiter contained TBIAb or inhibited TSH-stimulated cell growth or AC activation. The effect of IgG from hypothyroid nongoitrous cretins did not differ from that produced by IgG from hypothyroid cretins with goiter, euthyroid cretins with or without goiter, or normal controls. In contrast to these results, IgG from patients with autoimmune atrophic thyroiditis and from neonates with sporadic transient congenital hypothyroidism contained TBIAb that inhibited both TSH-stimulated cell growth and AC activation. In conclusion, our results indicate that, similar to other types of endemic cretinism, hypothyroid endemic cretins without goiter do not have TSH receptor antibodies able to inhibit TSH-stimulated thyroid cell growth or function. These observations argue against a role of humoral thyroid autoimmunity in the development of myxedematous endemic cretinism.
有报告指出,黏液水肿型地方性克汀病患者血清中存在甲状腺生长阻滞抗体,这提示甲状腺自身免疫在该病发病机制中起作用。为验证这一假说,我们在来自意大利和秘鲁的18例甲状腺功能正常和21例甲状腺功能减退的地方性克汀病患者的免疫球蛋白G(IgG)中,寻找具有甲状腺生长阻滞或腺苷酸环化酶(AC)抑制(TSH阻滞)活性的TSH受体抗体。在甲状腺功能减退的克汀病患者中,12例无可触及的甲状腺肿。18例甲状腺功能正常的克汀病患者中,12例有I - III期甲状腺肿。对照组包括25例生活在与克汀病患者相同地方性病区的甲状腺功能正常且无甲状腺肿的受试者,以及10例来自碘充足地区的正常受试者。研究纳入了4例自身免疫性萎缩性甲状腺炎患者和2例因母体TSH阻滞抗体导致散发性短暂先天性甲状腺功能减退的新生儿的IgG。通过测量TSH刺激的[³H]胸腺嘧啶掺入、DNA积累和AC激活,在FRTL - 5细胞中评估IgG的阻滞作用。采用放射受体分析法检测TSH结合抑制抗体(TBIAb)。无甲状腺肿的甲状腺功能减退的地方性克汀病患者的IgG中未含有TBIAb,也未抑制TSH刺激的细胞生长或AC激活。无甲状腺肿的甲状腺功能减退的克汀病患者的IgG的作用与有甲状腺肿的甲状腺功能减退的克汀病患者、有或无甲状腺肿的甲状腺功能正常的克汀病患者或正常对照组的IgG产生的作用无差异。与这些结果相反,自身免疫性萎缩性甲状腺炎患者和散发性短暂先天性甲状腺功能减退的新生儿的IgG含有TBIAb,可抑制TSH刺激的细胞生长和AC激活。总之,我们的结果表明,与其他类型的地方性克汀病相似,无甲状腺肿的甲状腺功能减退的地方性克汀病患者没有能够抑制TSH刺激的甲状腺细胞生长或功能的TSH受体抗体。这些观察结果反对体液性甲状腺自身免疫在黏液水肿型地方性克汀病发生中的作用。